Open | $3.610 |
Close | $3.520 |
Volume / Avg. | 601.209K / 667.068K |
Day Range | 3.355 - 3.670 |
52 Wk Range | 0.920 - 7.798 |
Market Cap | $221.287M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 22.92% |
Days to Cover | 19.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Omeros (NASDAQ: OMER) through any online brokerage.
Other companies in Omeros’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and SNDL (NASDAQ:SNDL).
The latest price target for Omeros (NASDAQ: OMER) was reported by Cantor Fitzgerald on Friday, November 10, 2023. The analyst firm set a price target for 0.00 expecting OMER to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Omeros (NASDAQ: OMER) is $3.52 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Omeros.
Omeros’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Omeros.
Omeros is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.